Pintea Andrada, Vlad Robert-Alexandru, Antonoaea Paula, Rédai Emöke Margit, Todoran Nicoleta, Barabás Enikő-Csilla, Ciurba Adriana
Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Cellular Biology and Microbiology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Polymers (Basel). 2022 Nov 18;14(22):5011. doi: 10.3390/polym14225011.
The development of semisolid formulations, gels in particular, has raised the attention of scientists more and more over the last decades. Because of their biocompatibility, hydrophilic nature, and capacity of absorbing large quantities of water, hydrogels are still one of the most promising pharmaceutical formulations in the pharmaceutical industry. The purpose of this study is to develop an optimal formulation capable of incorporating a water-poorly soluble active ingredient such as miconazole used in the treatment of fungal infections with and . A D-optimal design was applied to study the relationship between the formulation parameter and the gel characteristics. The independent parameters used in this study were the Carbopol 940 concentration (the polymer used to obtain the gel matrix), the sodium hydroxide amount, and the presence/absence of miconazole. Ten different dependent parameters (Y1-Y10) were evaluated (penetrometry, spreadability, viscosity, and tangential tension at 1 and 11 levels of speed whilst destructuring and during the reorganization of the gel matrix). The consistency of the gels ranged from 23.2 mm (GO2) to 29.6 mm (GM5). The least spreadable gel was GO7 (1384 mm), whilst the gel that presented the best spreadability was GO1 (3525 mm). The viscosity and the tangential stress at the selected levels (1 and 11) varied due to the different compositions of the proposed gels. The gels were also tested for drug content and antifungal activity. All determinations had satisfying results; the drug content was within limits accepted by Ph. Eur. 10 and all formulations containing miconazole exhibited antifungal activity. An optimal formulation with miconazole was attained, consisting of 0.84% Carbopol 940 and 0.32% sodium hydroxide.
在过去几十年中,半固体制剂尤其是凝胶剂的发展越来越引起科学家的关注。由于其生物相容性、亲水性以及吸收大量水分的能力,水凝胶仍然是制药行业中最有前景的药物制剂之一。本研究的目的是开发一种能够包含难溶性活性成分(如用于治疗真菌感染的咪康唑)的最佳制剂。采用D-最优设计研究制剂参数与凝胶特性之间的关系。本研究中使用的独立参数为卡波姆940浓度(用于获得凝胶基质的聚合物)、氢氧化钠用量以及咪康唑的有无。评估了10个不同的相关参数(Y1 - Y10)(在凝胶基质破坏和重组过程中,在1和11个速度水平下进行针入度、铺展性、粘度和切向张力测试)。凝胶的稠度范围为23.2毫米(GO2)至29.6毫米(GM5)。铺展性最差的凝胶是GO7(1384毫米),而铺展性最佳的凝胶是GO1(3525毫米)。由于所提出的凝胶组成不同,在选定水平(1和11)下的粘度和切向应力有所变化。还对凝胶进行了药物含量和抗真菌活性测试。所有测定结果均令人满意;药物含量在欧洲药典10认可的范围内,所有含咪康唑的制剂均表现出抗真菌活性。获得了一种含咪康唑的最佳制剂,其由0.84%的卡波姆940和0.32%的氢氧化钠组成。